Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Presentation

Multiplex targeting of immune checkpoints with compact zinc finger repressors to improve anti-tumor activity of T cells

Download PDF